|
|
||||||||||||
| ||||||||||||||||||||||||||||||
Question: Does sleep play a role in glucose metabolism and the development of type 2 diabetes?
Answer: Before I answer this question directly, I think it is important to note that Americans' sleep habits have changed significantly over the last century. The National Sleep Foundation's annual surveys of Americans' sleep habits indicate that Americans are sleeping less and less.1 Even though the average requirement for sleep is likely 8–9 hours, many Americans average <7 hours, with some getting 5–6 hours most of the time.2 Thus, sleep deprivation is endemic in our society.
With this as the backdrop, an increasing body of epidemiological and experimental data suggests that sleep deprivation hurts our overall health and functioning, and specifically may affect the development of diseases such as diabetes.
Epidemiological studies—largely conducted in men—have shown
fairly consistently that those who regularly sleep
5 hours, or >8
hours, are at some increased risk for developing type 2
diabetes.3,4
There is also evidence that individuals with type 2 diabetes who report poor
quality sleep or short sleep duration have increased glycated hemoglobin (A1C)
levels.5
Experimental studies also support this phenomenon and reveal some possible mechanisms for the relationship. Sleep loss in normal volunteers appears to significantly affect the hypothalamic pituitary system, as well as the autonomic nervous system, both of which in turn affect metabolism and, specifically, insulin resistance.6
Sleep curtailment alters the pattern of growth hormone secretion, reduces concentrations of thyroid stimulating hormone, and increases evening cortisol levels, all of which can be mechanisms for an increase in insulin resistance. Other characteristics of sleep deprivation are increased sympathetic activity and less parasympathetic activity, which also affect glucose metabolism and the release of insulin.
Yet more experimental data shed light on sleep deprivation's impact on hormones related to appetite and satiety. Sleep restriction appears related to reductions in the appetite suppressant leptin and elevations in the appetite stimulant ghrelin. As a result, people low on sleep tend to experience increased hunger and appetite, especially for foods with high carbohydrate content.7 Sleep loss, therefore, seems to alter the ability of leptin and ghrelin to accurately signal caloric need, and could lead to excessive caloric intake when food is freely available. Thus, sleep loss could drive individuals toward obesity, cardiometabolic risk, and sleep apnea.
Lastly, an increasing body of data indicates that obstructive sleep apnea is an independent risk factor for type 2 diabetes. Further, it appears that apnea may also be modulated through autonomic dysfunction and metabolic and endocrine changes that affect insulin resistance.8
I strongly recommend that individuals diagnosed with type 2 diabetes be
screened for obstructive sleep apnea syndrome, especially if they are
overweight. Similarly, physicians should be alert to the possibility of
impaired glucose tolerance or insulin resistance in patients who have
obstructive sleep apnea, particularly if those patients are overweight.
Footnotes
Do you have a clinical question? Send it to docnews{at}diabetes.org.
|
References
2. National Sleep Foundation: 2002 Sleep in America Poll. Washington, D.C., National Sleep Foundation. Available online at www.sleepfoundation.org/site/c.huIXKjM0IxF/b.2417355/k.143E/2002_Sleep_in_America_Poll.htm. Accessed September 12, 2007.
3. Yaggi HK, Araujo AB, McKinlay JB: Sleep duration as a risk factor
for the development of type 2 diabetes. Diabetes Care 29: 657–661, 2006.
4. Mallon L, Broman JE, Hetta J: High incidence of diabetes in men
with sleep complaints or short sleep duration: A 12-year follow-up study of a
middle-aged population. Diabetes Care 28: 2762–2767, 2005.
5. Knutson KL, Ryden AM, Mander BA, et al.: Role of sleep duration and
quality in the risk and severity of type 2 diabetes mellitus. Arch
Intern Med 166:1768–1774, 2006.
6. Van Cauter E, Knutson K, Leproult R, et al.: The impact of sleep deprivation on hormones and metabolism. Published online at http://www.medscape.com/viewarticle/502825 April 28, 2005. Accessed August 23, 2007.
7. Taheri S, Lin L, Austin D, et al.: Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index (BMI). Sleep 27:A146–A147, 2004.
8. Chasens ER, Weaver TE, Umlauf MG: Insulin resistance and
obstructive sleep apnea: Is increased sympathetic stimulation the link?
Biol Res Nurs 5:87–96, 2003.
| ||||||||||||||||||||||||||||||
|
||||||
|
| DOC News | Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |